The Inflation Reduction Act (IRA) is poised to have significant implications for many pharma companies in the near future. Review the resources below for up-to-date information on how the IRA came to be, implications for the industry, and insights on recent updates.
Latest News
Given the potential loss of countless new lifesaving treatments and of the ability to live longer, healthier lives, the gravity of the Inflation Reductin Act cannot be overstated.
Lindsay Bealor Greenleaf, JD, MBA, Solution Leader, Federal and State Policy
Seize The Opportunity
Submit an RFP
Submit an RFP and let’s determine how our team of experts can support your business.
Reimbursement
Michael Beebe, MA
Executive Vice President
Matt
Salo
Senior Advisor 
Mackenzie Sharp, MPH
Associate